SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-11-034948
Filing Date
2011-04-12
Accepted
2011-04-12 16:20:42
Documents
6
Effectiveness Date
2011-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A f58086dadefa14a.htm DEFA14A 29241
2 GRAPHIC f58086daf5808608.gif GRAPHIC 1180
3 GRAPHIC f58086daf5808602.gif GRAPHIC 6152
4 GRAPHIC f58086daf5808605.gif GRAPHIC 1396
5 GRAPHIC f58086daf5808606.gif GRAPHIC 1231
6 GRAPHIC f58086daf5808607.gif GRAPHIC 1217
  Complete submission text file 0000950123-11-034948.txt   46431
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-28298 | Film No.: 11755124
SIC: 2836 Biological Products, (No Diagnostic Substances)